ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,247.79
-0.41%
Dow Jones
39,112.16
-0.76%
Gold vs US Dollar
2,319.65
-0.48%
Brent Oil
84.095
-0.11%
Bitcoin
61,795.94
-0.01%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Regencell Bioscience Holdings Ltd (RGC)

  7. Regencell Bioscience Holdings Ltd (RGC) News

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RGC
DateTimeSourceHeadlineSymbolCompany
20/06/202414:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RGCRegencell Bioscience Holdings Ltd
02/01/202411:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RGCRegencell Bioscience Holdings Ltd
15/12/202311:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RGCRegencell Bioscience Holdings Ltd
27/10/202321:15Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:RGCRegencell Bioscience Holdings Ltd
15/06/202321:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
05/06/202311:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
17/03/202310:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
28/02/202314:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
04/01/202313:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
22/12/202212:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
31/10/202220:18Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:RGCRegencell Bioscience Holdings Ltd
12/09/202214:18Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
12/09/202214:15Business WireRegencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy TrialNASDAQ:RGCRegencell Bioscience Holdings Ltd
26/07/202213:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
07/06/202216:37ValueWalkGame-Stop Or Game-On? RGC Has It All And Twice MoreNASDAQ:RGCRegencell Bioscience Holdings Ltd
02/06/202221:17Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
18/05/202213:05Business WireRegencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment PeriodNASDAQ:RGCRegencell Bioscience Holdings Ltd
18/05/202212:58Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
16/05/202213:56Business WireRegencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEONASDAQ:RGCRegencell Bioscience Holdings Ltd
16/05/202212:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
16/05/202212:00Business WireRegencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEONASDAQ:RGCRegencell Bioscience Holdings Ltd
16/05/202211:51Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
26/04/202213:08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
04/04/202212:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
30/12/202121:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
15/12/202114:49Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RGCRegencell Bioscience Holdings Ltd
13/12/202113:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
17/11/202122:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
29/10/202113:32Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:RGCRegencell Bioscience Holdings Ltd
07/09/202121:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
 Showing the most relevant articles for your search:NASDAQ:RGC

Your Recent History

USOTC
INRLF
Valneva (PK)
BIT
P1XEE7
NLBNPIT1XEE7 20240920 320
USOTC
SGPTF
Sage Potash (QB)
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved